1491 related articles for article (PubMed ID: 18401260)
1. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
[TBL] [Abstract][Full Text] [Related]
2. Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
Quiroga I; McShane P; Koo DD; Gray D; Friend PJ; Fuggle S; Darby C
Nephrol Dial Transplant; 2006 Jun; 21(6):1689-96. PubMed ID: 16490743
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
[TBL] [Abstract][Full Text] [Related]
4. Duration of delayed graft function is an important predictor of 1-year serum creatinine.
Domínguez J; Lira F; Rebolledo R; Troncoso P; Aravena C; Ortiz M; Gonzalez R
Transplant Proc; 2009; 41(1):131-2. PubMed ID: 19249496
[TBL] [Abstract][Full Text] [Related]
5. Impact of cold ischemia time on renal allograft outcome using kidneys from young donors.
Hernández D; Estupiñán S; Pérez G; Rufino M; González-Posada JM; Luis D; Delgado P; Rodríguez A; Marrero D; Porrini E; Torres A
Transpl Int; 2008 Oct; 21(10):955-62. PubMed ID: 18564990
[TBL] [Abstract][Full Text] [Related]
6. Creatinine reduction ratio: a useful marker to identify medium and high-risk renal transplants.
Vilar E; Varagunam M; Yaqoob MM; Raftery M; Thuraisingham R
Transplantation; 2010 Jan; 89(1):97-103. PubMed ID: 20061925
[TBL] [Abstract][Full Text] [Related]
7. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
Mota A
Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
[TBL] [Abstract][Full Text] [Related]
8. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
Douzdjian V; Bhaskar S; Baliga PK; Rajagopalan PR
Clin Transplant; 1997 Aug; 11(4):294-8. PubMed ID: 9267718
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
Stratta RJ; Alloway RR; Lo A; Hodge EE
Transplant Proc; 2005 Oct; 37(8):3527-30. PubMed ID: 16298650
[TBL] [Abstract][Full Text] [Related]
10. Effect of initial slow graft function on renal allograft rejection and survival.
Humar A; Johnson EM; Payne WD; Wrenshall L; Sutherland DE; Najarian JS; Gillingham KJ; Matas AJ
Clin Transplant; 1997 Dec; 11(6):623-7. PubMed ID: 9408697
[TBL] [Abstract][Full Text] [Related]
11. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
12. Evolution of rejection rates and kidney graft survival: a historical analysis.
Marcén R; Fernández-Rodriguez A; Rodríguez-Mendiola N; Ponte B; Galeano C; Villafruela JJ; Teruel JL; Burgos FJ; Ortuño J
Transplant Proc; 2009; 41(6):2357-9. PubMed ID: 19715918
[TBL] [Abstract][Full Text] [Related]
13. Incidence and factors associated with delayed graft function in renal transplantation at Carlos Van Buren Hospital, January 2000 to June 2008.
Sáinz MM; Toro JC; Poblete HB; Perez LF; Nicovani VH; Carrera MG
Transplant Proc; 2009; 41(6):2655-8. PubMed ID: 19715994
[TBL] [Abstract][Full Text] [Related]
14. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
16. Importance of early adequate exposure to cyclosporine in renal transplant outcome: study of 1-year creatinine.
Dominguez J; Kompatzki A; Velasco A; Turpaud F; Norambuena R; Arenas J; Pais E; Llanos R; Cortes-Monroy G
Transplant Proc; 2005 Oct; 37(8):3358-60. PubMed ID: 16298595
[TBL] [Abstract][Full Text] [Related]
17. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.
Bronzatto EJ; da Silva Quadros KR; Santos RL; Alves-Filho G; Mazzali M
Transplant Proc; 2009 Apr; 41(3):849-51. PubMed ID: 19376369
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.
Martins L; Fonseca I; Almeida M; Henriques AC; Dias L; Sarmento AM; Cabrita A
Transplant Proc; 2005; 37(6):2755-8. PubMed ID: 16182802
[TBL] [Abstract][Full Text] [Related]
19. [Cold ischaemia time and outcome of renal transplantation].
Warlé MC; Cheung CL; Teerenstra S; Hoitsma AJ; van der Vliet JA
Ned Tijdschr Geneeskd; 2010; 154():B539. PubMed ID: 20298635
[TBL] [Abstract][Full Text] [Related]
20. Impact of delayed graft function and acute rejection on kidney graft survival.
Gjertson DW
Clin Transpl; 2000; ():467-80. PubMed ID: 11512359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
